An English Company is going through the process of obtaining a license to use a new vaccine, which prevents development of Meningitis- Type B. This Company has claimed that the said vaccine will be presented to the word in near future.
As reported by reporter for the site of Borderless Physicians, Meningitis is an inflammation of myelin and cerebral membrane, affecting most of the adolescences with a mortality of 14-15%. Many patients, who have recovered, are affected by permanent neural injuries or have lost their hearing forever.
Certain vaccines have been produced in order to campaign against Meningitis of types A and C. However, none of the said vaccines has been effective for Meningitis of Type B. Meningitis of Type A is the most prevalent type of the said disease in Africa.
Meningitis of Type B is the most common type of the said complication in Europe. This fatal disease kills one out of ten patients, who suffer from the said complication. Even if the said disease is treated, 1/5th of those patients who had this kind of disease suffer from neural or hearing complications forever.
On average, 1870 cases of Meningitis of Type B are reported ever year in England. 200 cases out of total reported ones die due to the said disease. Half of those who die because of this type of Meningitis are kids, who are below five years.
Furthermore, over 400 kids, suffering from the said disease are affected by severe complications namely impairment, blindness, deafness, and cerebral injuries.
Although it has been reported that vaccination plans for campaign against other types of Meningitis were successful in England, presently, there is no vaccine against Meningitis of Type B in the nation.
Meningo Cocci B or Meningitis of Type B is the most prevalent type of bacterium meningitis in England. This type of Meningitis is regarded as the most fatal diseases as well.
Since there are many varieties of Meningitis of Type B, producing respective vaccine, which could prevent development of the said disease is a difficult task.
Bexsero is the first vaccine, which prevents development of the fatal type of Meningo Cocci B, which in some cases leads to death only within a few hours.
European Medical Institute which supervises over a supervising organization of medicines in England has stated its auspicious decision to use the aforesaid vaccine. Thus, it so seems that this vaccine is effective and using the same is not dangerous either.
This is the first step, taken in confirming procedure of the said vaccine. According to the said report, authorization for use of the said vaccines will be issued within the next three months accordingly.

Scientists have produced a kind of headband. One may put this specific kind of headband on his/her forehead for 30 days every day in order to prevent migraine headaches.
This tool, which is called Cefaly, transmits electrical pulses to the nerve above eye bowel, controlling the sense inside and surrounding the eye.
As reported by Mehr, according to a study, of which results have been published in Neurology Journal, researchers have found that disabling headaches of the individuals who use this specific kind of headband have been decreased by about 1/3rd .
Using the said headband, number of individuals, whose migraine headaches have been reduced by 1/2nd , has been tripled.
Professor Jean Shonen, from Belgium University, stated: “This specific kind of headband is devised across the forehead and the patient must use the said headband for 20 minutes every day”. As stated by the above-named, this treatment causes side-effects.
The above-named researcher further added: “The results obtained from this fresh treatment method are too much similar to the medicines, prescribed for prevention of occurrence of migraine headaches. However, the said medicines usually cause many side-effects and eventually, the patients have to stop using the said medicines.
In this study, 67 persons, with four migraine seizures on average per month have been studied for four months, receiving no treatment.
The candidates were divided into two groups. One group was stimulated by electrical pulses for three months, 20 minutes every day. The second group was treated for the similar period, using a device (a device with electrical pulses of low or no effect).
Researchers have found that these underwent real irritation, number of days during which they suffer from migraine headaches has been decreased by 1/3 per month. It means that number of such days has been reached from seven to five days while no changes have been observed in another group using device.

Researchers of medical sciences are of this opinion that respective results of a research done on a few patients, suffering from colorectal cancer has shown that decrease of mortality only occurs by prescribing Aspirin for a group of patients, suffering from colorectal cancer. It should be noted that a mutation has been identified in CA3PIK gene of the aforesaid patients.
As reported by the reporter for the site of Borderless Physicians, Aspirin or “Acetylsalicylic Acid” is the highly-appreciated medicines all over the globe. Every year, 50,000 Millions of tablets of Aspirin are consumed through the world.
Following a 12-year research, researchers further added that during said period prescribing Aspirin to the patients, suffering from colorectal cancer, with such genetic mutation, described earlier, has decreased mortality caused by the said kind of cancer by 80%, compared to those patients, who have not taken the said medicine.
In Britain, every individual consumes 70 tables of Aspirin together with other pain killers, Caffeine or Vitamin C.
Further to its property as a pain killer, Aspirin is also a medicine used as refrigerant and anti-inflammation medicine. Moreover, consuming Aspirin has also indicated such side-effects as gastric ulcers and prevents blood clotting.
However, nowadays Aspirin is used in the following cases:
Prevention of cardiac disorders by 37.6%, arthritis by 23.3%, headache by 12.2%, body pains by 12.2% and other pains by 14.1%.
Other results obtained from this research reveal that this dropping trend of mortality has not been observed among other individuals, receiving Aspirin, but with no such genetic mutation as described earlier.
Colon and rectum cancer, which is also known as Colorectal Cancer, is the second main cause of death caused by cancers among men and the third main cause of death caused by cancers among women. On a whole, the five-year survival for colorectal is given as 58%, compared to other cancers, which are diagnosed at primary stages given as 89%.
It should be noted that following an appropriate diet such as eating low fat foods, eating fibers, fruits and vegetables as well as doing physical activities may prevent development of colorectal cancer.
The results obtained from the said research have been published in New England Medical Journal Accordingly.

A sub-specialist in cornea pointed that application of the new method of Femto-LASIK for treatment of cornea diseases and especially for correction of eye refractive disorders, and further added: “Using this kind of laser, surgeries on cornea is done more precisely and quickly in such a way as such operation takes less than one minute and the patient is able to resume his work the day after this surgery. Dr Seyed Javad Hashemian stated on the new method of Femto-LASIK used for treatment of cornea diseases: Femto-LASIK is one of the most modern method for correction of myopia and hyperopia as well as astigmatism. Femtosecond laser enjoys various applications in ophthalmology including making incisions on cornea, treatment of glaucoma and some complications with retina.
He further added: “Presently, this new system has been devised in many specialized eye hospitals. This kind of laser, with a length of 1053 is in the range of infrared lights. It is able to pass through various spaces, making incisions on each axle. Consequently, this kind of laser has helped us make kinds of surgical incisions on all directions and axles.
He further added: “Nowadays, this method is used in surgeries on cornea such as layer grafting and the surgeries, which does require that a stent be devised in cornea thickness. This stent is also used for correction of refractive disorders through a flap (making in incision on cornea). Respective advantages of the said surgery, which is done by the help of Femtosecond laser are namely more preciseness, less complications and high speed”. Stating that previously during provision method of flap using LASIK, error coefficient could have caused that the said flap lacks desirable quality and appearance”. He also stated: “However, such problems as described above have been removed now because accuracy of the said device in preparing the said flap is really at higher level and it is controllable as it has been made considering cornea cut cellulose structure. Thus, respective surgery may be design and performed proportionate to conditions of each patient.
The above-named sub-specialist in cornea has also emphasized on the fact that complications of such surgeries have decreased to a large extent and he added: “This method is useful especially for those who are not able to go through other methods including surface cornea laser, P.R.P and LASEK.    He also stated: “There are different methods, used for correction of refractive disorders. However, in the patients, who are candidates for LASIK surgery, the said operation shall be performed more precisely and reliably using femtolaser equipment”.

Researches of scientists of Oklahoma have revealed that fundamental cells, extracted from lipid tissue during liposuction process may be used for development of new blood vessels of low diameter, used in by-pass surgery and other processes accordingly.
Millions of patients, suffering from cardiovascular disorders do need grafting thin vessels for the processes, which do require return of blood to blocked vessels.  The vessels obtained from liposuction, which are developed in laboratories, may help solve the main problems, associated with grafting of blood vessels from other parts of body or artificial vessels, which are not live tissues.
The said researches have changed fundamental cells, obtained from lipid to soft muscular cells at laboratory and then, they develop the said cells on a thin membrane of Collagen, which has been devised inside a tube as much as a tiny blood vessel.
Researchers hope that they would be able to test the said prefabricated samples of the said technology on animals in the next six months.
The said research has been presented in scientific conferences of basic sciences of cardiology of American Heart Association.